Apixaban Impurity 35 | CAS 545445-44-1 - Request Quote
Apixaban Impurity 35
| SZ CAT No: | SZ-A062047 |
| CAS No | 545445-44-1 |
| Mol.F. | C20H25N3O3 |
| Mol.Wt. | 355.4 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Apixaban Impurity 35 is chemically 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one. Apixaban Impurity 35 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 35 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 545445-44-1
Purchase 545445-44-1
Order 545445-44-1
Enquire 545445-44-1
price of 545445-44-1
545445-44-1 Supplier
545445-44-1 Manufacturer
545445-44-1 Exporter
buy high quality Apixaban Impurity 35
Purchase Apixaban Impurity 35
Apixaban Impurity 35 suppliers
Apixaban Impurity 35 manufacturers
Apixaban Impurity 35 price
Order Apixaban Impurity 35
Enquire Apixaban Impurity 35
Apixaban Impurity 35 cost
Apixaban Impurity 35 Supplier
Apixaban Impurity 35 Distributor
Apixaban Impurity 35 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 35 for ANDA Filing
Apixaban Impurity 35 for Forced Degradation Studies
Apixaban Impurity 35 Identification Standards
Apixaban Impurity 35 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.